UK Edition
AdvertiseSubmit Company
Pharma JournalEvidence-Based Pharmaceutical Intelligence
CLINICAL RESEARCH

ABX-CRO

Contract research organisation specialising in radiopharmaceuticals

ABX-CRO logo

ABX-CRO

Contract research organisation specialising in radiopharmaceuticals

Visit WebsiteContact Company

About ABX-CRO

ABX-CRO operates as an independent full-service contract research organisation with a declared specialism in neuroscience, oncology and molecular imaging, applying a translational medicine approach to take compounds from early bench research through to clinical bedside application. The organisation's formal name, ABX-CRO advanced pharmaceutical services Forschungsgesellschaft mbH, reflects its German origins, and its footprint has expanded internationally through both organic growth and strategic acquisitions.

The service portfolio spans the full drug development continuum. On the clinical side, ABX-CRO provides radiopharmaceutical clinical trials, clinical operations, medical monitoring, pharmacovigilance, data management and biostatistics. Complementing these, the organisation offers imaging and dosimetry services alongside regulatory affairs support, preclinical and pharmacy capabilities, and project design and strategy consultancy. Medical device studies are also within scope.

Several milestones mark the company's recent expansion. ABX-CRO acquired ClinSmart LLC, a Pennsylvania-based clinical quality CRO described as well-established, extending its North American presence. In India, the company secured official registration and accreditation with CDSCO as a radiopharmaceutical CRO, enabling it to conduct radiopharmaceutical clinical trials in that market. Recognition from the scientific community has also followed: ABX-CRO and Isotope Technologies Munich jointly received the Marie Curie Award from the European Association of Nuclear Medicine (EANM), acknowledging their collaborative work in the nuclear medicine field.

The organisation additionally maintains an India office and a jobs programme, indicating sustained operational investment across multiple geographies.

Further information is available at abx-cro.com.

Areas of Expertise

Clinical OperationsMedical DevicesNeuroscienceOncologyPharmacovigilanceRadiopharmaceuticalsRegulatory Affairs

Services & Capabilities

Clinical OperationsMedical DevicesNeuroscienceOncologyPharmacovigilanceRadiopharmaceuticalsRegulatory Affairs
Similar Companies

More in Clinical Research

A

Agilex Biolabs

As the only FDA-inspected bioanalytical laboratory of its type in Australia, Agilex Biolabs occupies a distinctive position in the Asia-Pacific clinical trial services market. Based in Australia, the company serves contract research organisations and sponsors requiring rigorous bioanalytical and toxicology support throughout drug development. The laboratory's core capability is pharmacokinetics (PK) analysis, covering the full time course of drug absorption, bioavailability, distribution, metabolism, and excretion. Complementing this is pharmacodynamics (PD) work, which addresses the biochemical, physiological, and molecular effects of a therapeutic on the body. Together, these services provide sponsors with an integrated view of drug behaviour in clinical studies. Agilex Biolabs operates across several analytical disciplines. LC-MS/MS bioanalysis and immunoassays (ligand binding assays) underpin small and large molecule quantification. The team also conducts immunogenicity testing, including anti-drug antibody and neutralising antibody assays, alongside vaccine and cell-based immunology assays and flow cytometry. Biomarker services are an active component of the offering, providing efficacy, safety, and pathology data relevant to the indication under investigation. For multi-site programmes, the laboratory provides end-to-end central lab services, managing the entire sample lifecycle including kit production and distribution to clinical sites. Off-the-shelf assays are available to reduce time and cost for sponsors with more standard bioanalytical requirements. The company's FDA-inspected status makes it a credible option for global programmes requiring a compliant Southern Hemisphere facility, particularly where an Australian clinical footprint or regulatory alignment is relevant to the development strategy. Further information is available at agilexbiolabs.com.

View profile
R

RSSL

RSSL (Reading Scientific Services) operates across two major industry verticals, providing contract laboratory and scientific services to clients in life sciences and pharmaceuticals as well as food and consumer goods. Based in Reading, UK, the organisation positions itself as an outsourced testing and innovation partner covering everything from early research and discovery through to manufacturing, commercialisation, and regulatory compliance. Within the pharmaceutical and life science sector, RSSL offers testing across a broad range of molecule and product types, including biologics, cell and gene therapy, consumer healthcare, small molecule pharmaceuticals, vaccines, veterinary medicine, and specialised nutritional products. Services are organised by development phase, allowing clients to engage at preclinical stages, through clinical development, and into commercial-scale manufacturing. Capabilities span pharmacopoeial testing, ICH stability studies, contamination and impurity analysis, microbiology testing, and a rapid mycoplasma screening and detection service, which the company describes as fast, compliant, and sensitive. A priority response service is also available for time-critical projects. RSSL maintains an Innovation Hub and a dedicated services directory spanning techniques and methods to support product development across its client base. The food and consumer goods division extends these analytical capabilities into food and beverages, ingredients, consumer goods, food service, specialised nutrition, nutraceuticals, and dietary supplements. A recently announced dedicated nutritional testing service, supported by a £1.2 million investment, reflects continued capital commitment to expanding laboratory capacity in this area. Further information is available at rssl.com.

View profile
A

Affinity

Combining mobile nursing, teletrials and a dedicated oncology unit, Affinity Clinical Research Services brings clinical research capability directly to patients across Perth and the wider Australian continent. Operating from Doubleview in Western Australia and from a research facility within Hollywood Private Hospital Medical Centre, the organisation serves pharmaceutical sponsors, biotechnology companies and independent investigators seeking a flexible, patient-centred site partner. Affinity's service model covers the full research lifecycle, from protocol development and site feasibility through participant recruitment, data collection and publication support. The company's direct-to-patient and mobile trial services reduce the burden on participants who would otherwise be unable to access a fixed trial site, extending sponsor reach into regional and rural populations. This approach aligns with ICH-GCP guidelines and is adapted to the specific needs of each patient group and study design. The dedicated oncology division, Affinity Oncology, was established in 2016 and draws on clinical staff with more than a decade of experience in cancer trials. On-site resources include PET/CT imaging, a compounding pharmacy and a chemotherapy infusion suite, allowing complex oncology studies to run without reliance on third-party facilities. Beyond oncology, Affinity supports studies across a broad range of therapeutic areas and can assist private investigators running sponsor-initiated or investigator-initiated research. Further information is available at affinityresearch.com.au.

View profile
AdvertisementTeksyte LTD

List Your Company

Showcase your company to thousands of pharma professionals.

Submit Listing

Advertise With Us

Reach decision-makers in the pharmaceutical industry.

Learn More

We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy